Carlyle Group Inc. Portfolio Holdings

Carlyle Group Inc.

  • $100 Million
  • Q4 2024

Carlyle Group Inc. has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $100 Million distributed in 27 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Phathom Pharmaceuticals, Inc. with a value of $28.4M, Vector Holding, LLC with a value of $18.5M, Invitation Homes Inc. with a value of $15.3M, Cube Smart with a value of $9.45M, and Seacor Marine Holdings Inc. with a value of $8.89M.

Examining the 13F form we can see an decrease of $564M in the current position value, from $664M to 100M.

Carlyle Group Inc. is based out at Washington, DC

Below you can find more details about Carlyle Group Inc. portfolio as well as his latest detailed transactions.

Portfolio value $100 Million
Healthcare: $36.2 Million
Real Estate: $24.7 Million
Communication Services: $18.5 Million
Industrials: $12.4 Million
Consumer Cyclical: $3.46 Million
Consumer Defensive: $3.38 Million
Technology: $1.11 Million
Energy: $315,000
Other: $0

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$219M
$28.4 Million 28.4% of portfolio
3,496,808
Q2 2023 Added 19.14%
$635M
$18.5 Million 18.5% of portfolio
8,684,599
Q4 2024 Reduced 5.73%
$20.7B
$15.3 Million 15.27% of portfolio
477,500
Q1 2023 New
$9.38B
$9.45 Million 9.45% of portfolio
220,500
Q3 2022 New
$130M
$8.89 Million 8.89% of portfolio
1,355,761
Q4 2024 Added 1.81%
$59.5M
$3.75 Million 3.75% of portfolio
1,838,486
Q1 2023 New
$298M
$3.46 Million 3.46% of portfolio
4,810,209
Q2 2022 New
$595M
$3.46 Million 3.46% of portfolio
107,214
Q3 2024 New
$1.01B
$3.38 Million 3.38% of portfolio
340,748
Q1 2024 New
$34.8M
$2.83 Million 2.83% of portfolio
2,948,718
Q1 2024 Added 39.39%
$8.25M
$1.19 Million 1.19% of portfolio
2,896,518
Q1 2023 New
$1.3B
$875,000 0.88% of portfolio
93,732
Q1 2024 New
$562M
$315,000 0.32% of portfolio
9,880
Q4 2024 New
$38.6B
$232,000 0.23% of portfolio
6,242
Q4 2024 New
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 66.21%
Spyre Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2023 New
Exicure Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 399.99%
Ramaco Res Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Q32 Bio Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Pony Ai Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Onkure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Nucana PLC
-
$0 0.0% of portfolio
-
Q2 2024 New
Maplebear Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 39.98%
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Complete Solaria Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 59.51%
Weride Inc
-
$0 0.0% of portfolio
-
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 27
  • Current Value $100 Million
  • Prior Value $664 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 13, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 7 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Carlyle Group Inc. Portfolio

Follow Carlyle Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlyle Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carlyle Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email